Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition. 1979

C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D003070 Coformycin A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.
D003838 Deoxyadenine Nucleotides Adenine nucleotides which contain deoxyribose as the sugar moiety. Deoxyadenosine Phosphates,Nucleotides, Deoxyadenine,Phosphates, Deoxyadenosine
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
D058892 Adenosine Deaminase Inhibitors Drugs that inhibit ADENOSINE DEAMINASE activity. ADA Inhibitors,Deaminase Inhibitors, Adenosine,Inhibitors, ADA,Inhibitors, Adenosine Deaminase

Related Publications

C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
January 1979, Advances in experimental medicine and biology,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
April 1986, Cancer research,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
September 1981, British journal of haematology,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
November 1981, Cancer research,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
July 1980, Lancet (London, England),
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
February 1980, Biochemical pharmacology,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
January 1980, Cancer chemotherapy and pharmacology,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
September 1981, Cancer research,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
December 1989, Teratology,
C A Koller, and B S Mitchell, and M R Grever, and E Mejias, and L Malspeis, and E N Metz
August 1979, Cancer research,
Copied contents to your clipboard!